Nationwide Fund Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-156,249
Closed -$3.24M 2716
2017
Q3
$3.24M Buy
156,249
+49,749
+47% +$841K 0.01% 1224
2017
Q2
$1.58M Buy
106,500
+76,376
+254% +$1.27M 0.01% 1539
2017
Q1
$480K Sell
30,124
-2,506
-8% -$36.1K ﹤0.01% 2178
2016
Q4
$411K Buy
32,630
+2,661
+9% +$49.6K ﹤0.01% 2285
2016
Q3
$839K Sell
29,969
-29,846
-50% -$1M ﹤0.01% 1890
2016
Q2
$2.09M Buy
59,815
+2,348
+4% +$73.8K 0.01% 1334
2016
Q1
$1.59M Sell
57,467
-17,734
-24% -$522K 0.01% 1468
2015
Q4
$2.57M Buy
75,201
+10,835
+17% +$338K 0.01% 1246
2015
Q3
$1.85M Buy
64,366
+15,680
+32% +$670K 0.01% 1409
2015
Q2
$2.18M Buy
48,686
+11,442
+31% +$430K 0.01% 1384
2015
Q1
$1.29M Buy
37,244
+16,319
+78% +$444K 0.01% 1756
2014
Q4
$573K Buy
+20,925
New +$508K ﹤0.01% 2103

Other funds holding DPLO

Nationwide Fund Advisors's DPLO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 156,249 shares — an estimated $3.24M sold.

Nationwide Fund Advisors first reported a position in DPLO in Q4 2014 and held it in 12 quarters. The position peaked at $3.24M in Q3 2017. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 156,249 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $3.24M.
  • Nationwide Fund Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's DIPLOMAT PHARMACY, INC. position peaked at $3.24M in Q3 2017.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.